Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Disease area: Sleep and breathing disorders

Abstract

Background. The aim of the study was to evaluate the prevalence of metabolic syndrome (MS) in patients with hypertension and obstructive sleep apnea (OSA) and find out, if the MS patients have worse parameters of blood pressure and obstructive sleep apnea than without MS.
Methods. 110 patients (97 males) with OSA and hypertesion were evaluated for presence of MS (ATP score). Statistical correlation MS+, MS- of the value of blood pressure (BP) (ambulatory BP monitoring) and OSA - AHI (apnea- hypopnea index), ODI (oxygen desaturation index)- chí square, t-test, Mann Whitney test.
Results. MS was present in 86 patients (75 males) (average age 54±9,3). There were no differences between MS+ and MS- in age (54,75±9,3 v. 50,63 ±11,8, p= 0,075), weight (106,79±18,98 v. 101,75±26,1, p=0,294), BMI (35,13±5,3 v. 33,43± 7,9, p=0,231), waist size (117,6±11,1 v. 112,33±21,8, p=0,93), AHI (44,95±25,22 v. 35,72±23,26, p=0,11), ODI (47,17±25,33 v.38,37±17,1, p=0,228), average systolic BP over 24 hours (133,38±13,5 v. 132,46±14,75, p=0,773), average diastolic BP over 24 hours (78,83±8,8 v. 77,79±7,7, p= 0,606), average systolic BP at night (130,5±15,3 v. 124,78±15,4, p= 0,115), average diastolic BP at night (75,74±9,5 v. 71,91±7,2, p= 0,077).
Conclusions. Patients with OSA, hypertension and MS were found not to have worse BP and OSA parameters than the patients without MS.
Supp. by MSM Czech rep. 6198959216.

Rating:

Share or cite this content

Citations should be made in the following way:
M. Hobzova, E. Sovova, M. Sova, P. Zmeškal, V. Kolek, K. Langova (Olomouc, Czech Republic). Prevalence of metabolic syndrome in patients with hypertension and obstructive sleep apnea. Eur Respir J 2009; 34: Suppl. 53, 3677

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of metabolic syndrome from patient with obstructive sleep apnea and hypertension Source: International Congress 2019 – Current perspectives in sleep-disordered breathing Year: 2019 The influence of obesity in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 295s Year: 2002 The prevalance of cardiovascular disorders in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 293s Year: 2002 Prevalence of very severe obstructive sleep apnea syndrome from symptomatic patients. Source: International Congress 2019 – Screening tools, prevalence and predictors of obstructive sleep apnoea Year: 2019 Prevalance and characteristics of overlap syndrome in patients with obstructive sleep apnea Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002 Predictors of obstructive sleep apnea syndrome and metabolic syndrome Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism Year: 2011 Arterial hypertension in patients with obstructive sleep apnoea and overlap syndrome Source: Annual Congress 2009 - Control of breathing and respiratory disorders during sleep Year: 2009 The evaluation of risk of obstructive sleep apnea syndrome in individuals with dysglycaemia Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012 Prevalence of glaucoma in obstructive sleep apnea syndrome Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness Year: 2010 Investigation of the prevalence of obstructive sleep apnea syndrome in patients with diagnosed subclinicalhypothyroidism Source: Sleep and Breathing Conference 2021 Year: 2021 Metabolic syndrome in obstructive sleep apnoea patients Source: Annual Congress 2007 - Sleep apnoea Year: 2007 Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea Year: 2009 Frequency and importance of metabolic syndrome in obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 414s Year: 2006 Prevalance of daytime hypercapnia in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 574s Year: 2002 Should patients with obstructive sleep apnea syndrome be screened for hypothyroidism? Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005 Treatment control in risk patients with obstructive sleep apnea syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 411s Year: 2006 Unrecognised hypertension in patients screened for obstructive sleep apnoea Source: Eur Respir J 2005; 26: Suppl. 49, 40s Year: 2005 Masked hypertension and obstructive sleep apnea syndrome (OSAS) Source: Eur Respir J 2006; 28: Suppl. 50, 416s Year: 2006 Comorbidities of obstructive sleep apnoea syndrome Source: Annual Congress 2011 - Comorbid obstructive sleep apnoea (OSA) and OSA comorbidities Year: 2011 Investigation of various factors in obstructive sleep apnea syndrome patients Source: Eur Respir J 2006; 28: Suppl. 50, 194s Year: 2006